ADMA BIOLOGICS, INC. Quarterly Return On Equity in % from Q1 2012 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adma Biologics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q4 2024.
  • Adma Biologics, Inc. Return On Equity for the quarter ending December 31, 2024 was 85.7 %.
  • Adma Biologics, Inc. annual Return On Equity for 2024 was 85.7 %.
  • Adma Biologics, Inc. annual Return On Equity for 2023 was -19.5 %, a 63.5% increase from 2022.
  • Adma Biologics, Inc. annual Return On Equity for 2022 was -53.4 %, a 12.8% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.